Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C. - Wikidata - awgldk - TriplyDB

Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C.

Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C.

http://www.wikidata.org/entity/Q43034289

about

Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2.Zinc in Infection and Inflammation.Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial.Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami.The use of selected nutrition supplements and complementary and alternative medicine in liver disease.Antioxidants as therapeutic agents for liver disease.Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C.The zinc transporter Zip14 influences c-Met phosphorylation and hepatocyte proliferation during liver regeneration in mice.Blood cell, liver function, and response changes by PEG-interferon-alpha2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis Impact of the discovery of human zinc deficiency on health.Zinc and liver disease.Can zinc enhance response interferon therapy for patients with HCV-related liver disease?Zinc is a negative regulator of hepatitis C virus RNA replication.Zinc-Responsive Necrolytic Acral Erythema in a Patient With Psoriasis: A Rare Case.Serum Zinc and Haptoglobin in Noncirrhotic Azeri Patients with Chronic Active Hepatitis C: a Case-Control Study.Clinicopathological and prognostic significance of preoperative serum zinc status in patients with hepatocellular carcinoma after initial hepatectomy.Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent.Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease.Hepatic metallothionein in patients with chronic hepatitis C: relationship with severity of liver disease and response to treatment.Polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice.The antiviral role of zinc and metallothioneins in hepatitis C infection.Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease.Interferon-alpha-2a and zinc combination therapy in children with chronic hepatitis B infection.Viusid, a nutritional supplement, in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C.

P2860

Q33788596-9081899E-4F3C-4C29-A5F4-A0EAA6C197BA Q33852159-BF980FB7-3B75-4CEE-BBAF-CE6D0DC23E05 Q34013192-DE972167-5A4B-4CB9-91E7-B5EE908AB8D6 Q34279897-FD46A38E-5E17-4708-8E91-BE212EC99195 Q34554574-91003340-9543-4579-B726-F09D496B6074 Q35585469-B67BCC25-434D-4164-80A2-F8C93206C86C Q36190363-DCD54BC7-49A2-4308-B748-C15DAD2D0E2D Q36792806-2E97E25B-9F39-47CE-A2DC-F05A36594F1C Q37278198-D0E69574-92D1-4B7E-81A3-041982F4F3F5 Q37407491-9A859743-E9A1-459B-9FDC-F3CD703F9E02 Q37691145-8C5507EB-B9C3-4010-B9D4-25DE9D6B56D3 Q37981597-74205077-551F-425A-9AC9-54FC410CAD54 Q38025376-1D86D1C3-5533-42A6-9FB9-AD9B4C922D8D Q40221698-DAC25A2D-FF88-4BF9-874E-FB1804093106 Q40641856-47F3CF1E-87E8-4F2E-A9F5-B368F5915E38 Q41400511-0B472209-B082-45FF-9AE7-AF4188FB17DD Q42217842-4465EBDD-3D9A-471B-BD97-3CDEDE51FE81 Q42236944-651DEB2C-A8F0-4AE5-82C0-153F0415479C Q43040192-1FC01E90-7E13-4DC9-A4B7-49B0E769DC07 Q43048096-D9A74E8E-4C6E-44FA-A1ED-AF10B6E9FE29 Q46840361-8D5E2D82-6FDB-4296-85DF-B56DC0CBD9DB Q47295182-97F924D4-59DA-4B23-9DDF-C00B275BE414 Q49232850-0430EC4B-E085-44A3-91E0-0C917CB1686A Q50557331-2305A128-EBBA-4CD3-825A-720FF02DF8AC Q50573993-15587952-69A9-4C56-9CAD-36602EC56875

P2860

Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C.

http://www.wikidata.org/entity/Q43034289

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Zinc supplementation enhances ...... ents with chronic hepatitis C.

@en

Zinc supplementation enhances ...... ents with chronic hepatitis C.

@nl

type

label

Zinc supplementation enhances ...... ents with chronic hepatitis C.

@en

Zinc supplementation enhances ...... ents with chronic hepatitis C.

@nl

prefLabel

Zinc supplementation enhances ...... ents with chronic hepatitis C.

@en

Zinc supplementation enhances ...... ents with chronic hepatitis C.

@nl

P1433

Q43034289-69184590-C5B0-4DAD-B4D8-F36313D0A3BB

P1476

Q43034289-9B61F5C5-C2AC-4000-A1D0-406CB282AA2D

P2093

Q43034289-4574D102-7FB0-4024-9B68-41BC57ADE672

Q43034289-4A0C54A8-07AB-440F-93EB-B00A0F90CEC8

Q43034289-5CAA7C6B-3EBE-4E48-BA4F-49DC76846A61

Q43034289-618163C2-09F3-4D30-8BC5-65CBBD2B921E

Q43034289-64773562-0231-41AE-B05E-98914C5A9283

Q43034289-82391922-7B45-48DD-972F-BA0943DFC4FC

Q43034289-8C9144C2-D945-4879-A197-8CB04A4962B0

Q43034289-9409FBA0-EDAF-4072-A98A-5B06C35D9CFE

Q43034289-9DDEFC25-1AC3-4F36-AC4E-FCA5EE7014FA

Q43034289-A81E3BF5-5C07-4551-9AB1-D847DECEFCCF

P2860

Q43034289-0DB67CB4-E663-4D0D-B261-CFCD0496D76C

Q43034289-27972695-C1BB-4699-9195-261FB0913E3C

Q43034289-2A914E93-812A-4024-8C25-B10D9E09323D

Q43034289-4B843840-40D4-4165-ACEB-BE75F7DFB9CD

Q43034289-586F4165-037E-4B95-BD8A-E30CD239C783

Q43034289-70170613-C5A7-4FC1-ABFA-8D081C2D7C02

Q43034289-83CACFE9-7B0F-44CE-A435-214F315137E0

Q43034289-B4188A31-0A08-4682-9A2A-9EFB4FEB090E

Q43034289-B4E75228-0441-411A-85F1-9A0F9DB45E2B

Q43034289-DB90C60F-0D4B-457C-9C21-3C2CD29AB831

P304

Q43034289-05FF2B5B-E1FE-4F9A-B834-3269994670FD

P31

Q43034289-06840381-B1FB-4682-91FC-668B774E06B0

P356

Q43034289-AB1CBCFB-1A9A-4A2C-93E3-29F392CF8B0B

P433

Q43034289-FCEA966B-C883-4072-958F-E85E4DBFB8AB

P478

Q43034289-0FDBFA05-0CF3-4680-ABD8-C0DA7ED3E63D

P577

Q43034289-3E93FDCB-09A7-450A-8381-ADB1E14F830B

P698

Q43034289-80DB8A39-E7D9-44B4-AD3D-A47B9530304F

P356

J.1365-2893.2001.00311.X

P1433

Journal of Viral Hepatitis

P1476

Zinc supplementation enhances ...... ents with chronic hepatitis C.

@en

P2093

A Kojima

http://www.w3.org/2001/XMLSchema#string

H Takagi

http://www.w3.org/2001/XMLSchema#string

H Takayama

http://www.w3.org/2001/XMLSchema#string

J Takezawa

http://www.w3.org/2001/XMLSchema#string

K Sato

http://www.w3.org/2001/XMLSchema#string

K Suzuki

http://www.w3.org/2001/XMLSchema#string

M Mori

http://www.w3.org/2001/XMLSchema#string

S Kakizaki

http://www.w3.org/2001/XMLSchema#string

S Sato

http://www.w3.org/2001/XMLSchema#string

T Abe

http://www.w3.org/2001/XMLSchema#string

P2860

Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Inhibition of HIV-1 infection by zinc group metal compounds

Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis.

Zinc and immunoresistance to infection in aging: new biological tools.

Zinc supplementation and stunted infants in Ethiopia: a randomised controlled trial.

Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.

Evaluation of twice-daily administration of interferon-beta for chronic hepatitis C.

N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study.

Effects of zinc L-carnosine on gastric mucosal and cell damage caused by ethanol in rats. Correlation with endogenous prostaglandin E2.

P304

367-371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2893.2001.00311.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2001-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11555194

http://www.w3.org/2001/XMLSchema#string